Medidata Partner Program - Study Suspension Policy


The purpose is to define the procedure for addressing suspension of a study subject to an executed Sales Order (“SO”) or Statement of Work (“SOW”), as amended with Partner/Business Partner (herein collectively referred to as “Partner”).


  • Studies which are suspended by Partner;

  • Single study SO/SOW where there is an Application Services Fee;

  • Studies deployed under enterprise subscription SO/SOWs are not applicable to this Policy.


In the event that a Customer determines that a study must be suspended, then Partner may suspend the applicable SO/SOW. In the event of a study suspension, Partner will provide written notification to Medidata. Such notification to suspend must be received by Medidata at least thirty (30) days in advance of the effective date of the study suspension date. The suspension will be applied to applicable Partner study for a minimum period of three (3) months and a maximum of six (6) months. Partner shall pay a monthly suspension fee equal to fifteen (15%) percent of the monthly Application Services Fee as reflected in the SO/SOW. Suspension fees shall not apply to study suspensions prior to production software availability. Partner and Medidata shall document the suspension in an Amendment to the applicable SO/SOW.